Dániel Déri

Mr. Dániel Déri

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2022 in Journal of Water and Health
Verified
Journal Article
Open access
PDF file
EREszter Róka
Eszter Róka
DDDániel Déri
Dániel Déri
BKBernadett Khayer
Bernadett Khayer
Zoltan KisZoltan Kis
Zoltan Kis
ESEszter Schuler
Eszter Schuler
MVMárta Vargha
Márta Vargha
Wastewater-based epidemiology (WBE) is a recognised tool for tracking community transmission of COVID-19. From the second half of 2020, the emergence of new, highly infective, more pathogenic or vaccine-escape SARS-CoV-2 variants is the major public health concern. Variant analysis in sewage might assist the early detection of new mutations. Weekly raw sewage samples from 22 wastewater treatment plants (WWTPs) in Hungary (representing 40% of the population) were analysed between December 2020 and March 2021 for signature mutations N501Y and del H69/V70 of B.1.1.7 lineage by melting point genotyping and RT-digital droplet PCR (RT-ddPCR). The latter method proved to be more efficient in parallel detection of different variants and also provides quantitative information. Wastewater surveillance indicated that the B.1.1.7 variant first emerged in Budapest in early January 2021 and rapidly became dominant in the entire country. Results are in close agreement with the available clinical data (Pearson's correlation coefficient, R = 0.9153). RT-ddPCR was confirmed to be a reliable tool for tracking emerging variant ratios in wastewaters. It is a rapid and cost-effective method compared to whole-genome sequencing, but only applicable for the detection of known mutations. Efficient variant surveillance might require the combination of multiple methods.

29 May 2024 in Viruses
Verified
Journal Article
Open access
PDF file
NDNóra Deézsi-Magyar
Nóra Deézsi-Magyar
Béla DénesBéla Dénes
Béla Dénes
BNBereniké Novák
Bereniké Novák
GZGyula Zsidei
Gyula Zsidei
DDDániel Déri
Dániel Déri
KZKis Zoltan
Kis Zoltan
(1) Background: Crimean–Congo hemorrhagic fever (CCHF) is an emerging tick-borne disease endemic in Africa, Asia, the Middle East, and the Balkan and Mediterranean regions of Europe. Although no human CCHF cases have been reported, based on vector presence, serological evidence among small vertebrates, and the general human population, Hungary lies within high evidence consensus for potential CCHF introduction and future human infection. Thus, the aim of our pilot serosurvey was to assess CCHF seropositivity among cattle and sheep as indicator animals for virus circulation in the country. (2) Methods: In total, 1905 serum samples taken from free-range cattle and sheep in 2017 were tested for the presence of anti-CCHF virus IgG antibodies using commercial ELISA and commercial and in-house immunofluorescent assays. (3) Results: We found a total of eleven reactive samples (0.58%) from five administrative districts of Hungary comprising 8 cattle and 3 sheep. The most affected regions were the south–central and northwestern parts of the country. (4) Conclusions: Based on these results, more extended surveillance is advised, especially in the affected areas, and there should be greater awareness among clinicians and other high-risk populations of the emerging threat of CCHF in Hungary and Central Europe.

31 December 2025 in BMC Biotechnology
Verified
Journal Article
Open access
PDF file
UBUrban Bezeljak
Urban Bezeljak
AJAlexander Jerman
Alexander Jerman
TKTina Kobal
Tina Kobal
MKMartina Lokar Kosmač
Martina Lokar Kosmač
EBElfi Birsa
Elfi Birsa
MPMatjaž Peterka
Matjaž Peterka
Nipah virus (NiV) is an emerging high-fatality zoonotic threat lacking approved vaccines. Current virus-like particle (VLP) production methods rely on cost

24 August 2025 in bioRxiv
Verified
Preprint
Open access
UBUrban Bezeljak
Urban Bezeljak
AJAlexander Jerman
Alexander Jerman
TKTina Kobal
Tina Kobal
MKMartina Lokar Kosmač
Martina Lokar Kosmač
EBElfi Birsa
Elfi Birsa
MPMatjaž Peterka
Matjaž Peterka
Nipah virus (NiV) is an emerging high-fatality zoonotic threat lacking approved vaccines. Current virus-like particle (VLP) production methods rely on costly mammalian cell systems and non-scalable ultracentrifugation purification. We developed an efficient production system for enveloped NiVLPs by co-expressing structural proteins F, G, and M using a baculovirus expression vector system in Sf9 cells. A novel multi-step chromatographic purification process was established using monolith convective media, integrating steric exclusion chromatography with sequential cation and anion exchange steps. Purified NiVLPs were characterized by nanoparticle tracking analysis and transmission electron microscopy, then evaluated for immunogenicity in Syrian golden hamsters. The optimized process yielded enveloped particles of approximately 100-120 nm that morphologically resemble native NiV virions. A single 25 μg NiVLP dose induced robust systemic anti-NiV G IgG responses within 14 days, demonstrating rapid immunogenicity suitable for outbreak response. However, neutralizing antibody titers against NiV remained limited compared to total IgG responses. This study establishes the first chromatography-based manufacturing platform for morphologically correct NiVLPs from insect cells. A deeper understanding of the immunity generated is needed to support their potential as a rapidly deployable vaccine platform against NiV.